Metropolis Healthcare Reports Strong Q2 & H1FY27 Financial and Operational Performance
Metropolis Healthcare Ltd 路 Investor Presentation 路 04 Nov 2026, 1:09 am
Metropolis Healthcare Reports Strong Q2 & H1FY27 Financial and Operational Performance Metropolis Healthcare reported Q2FY27 revenue of INR 496.8 Cr (up 15.8% YoY), EBITDA of INR 134.9 Cr (up 23.9% YoY; 27.2% margin, +180 bps YoY), and PAT of INR 75.5 Cr (up 42.7% YoY; 15.2% margin, +290 bps YoY). H1FY27 revenue reached INR 947.0 Cr (+16.2% YoY) with PAT at INR 132.4 Cr (+34.9% YoY). Growth was volume-driven without price hikes, with patient volumes up 10% YoY to 4.07 Mn and test volumes up 11% YoY to 8.68 Mn in Q2FY27. Specialty and TruHealth segments grew 20% YoY each.
Original exchange filing (PDF)
More announcements from Metropolis Healthcare Ltd
- Transcript of Q2 and H1 FY27 earnings conference call held on November 04, 2026 路 10 Nov 2026
- Schedule of Analyst / Institutional Investor Meeting 路 05 Nov 2026
- Link of the audio recording of the earnings conference call held on November 04, 2026 路 04 Nov 2026
- Press Release 路 04 Nov 2026
- Board approves Interim Dividend 路 04 Nov 2026
- Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended September 30, 2026 路 04 Nov 2026
- Metropolis Healthcare Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 04 Nov 2026
- Outcome of Board Meeting 路 04 Nov 2026
